JPMorgan enters Korean OTC derivatives market
OTC licence approval gives JPMorgan an opportunity to grow its onshore client base.
JPMorgan is set to start trading over-the-counter OTC derivatives in South Korea after winning approval from local regulators earlier this week.
The initial focus will be on the equity market, but the licence, which is issued by the Financial Supervisory Commission, approves JPMorgan to market and trade the full range of OTC derivatives. The motivation was initially driven by the equity business but the platform is also designed for other asset classes, such as credit and rates, FX...
To continue reading, please login or register for free